Zusammenfassung
Neben den auch heute noch gebräuchlichen und häufig eingesetzten klassischen äußerlichen Behandlungskonzepten mit Dithranol oder Kortikosteroiden haben die topisch anwendbaren Vitamin-D3-Präparate oder Vitamin-D3-Analoga sowie topische Retinoide breite Verwendung gefunden. Kombinationen dieser neueren topischen Antipsoriatika sowohl untereinander als auch mit UV-Licht oder mit systemisch wirksamen Medikamenten haben oft eine größere therapeutische Effizienz als entsprechende Monotherapien. Besonders häufig wird in der Praxis bei Patienten mit leichter bis mittelschwerer Psoriasis die Kombination von Calcipotriol mit topischen Kortikosteroiden eingesetzt, die 2-mal täglich sequenziell, neuerdings auch 1-mal täglich in fixer Kombination angewendet werden kann. Auch bei schweren Formen der Psoriasis, die einer systemischen Behandlung bedürfen, ermöglicht eine zusätzliche wirksame topische Therapie ein besseres Langzeitmanagement.
Abstract
Classical topical treatment regimens in psoriasis including dithranol and corticosteroids are widely used and have been supplemented in recent years by topical vitamin D preparations, by vitamin D analogues and topical retinoids.The combination of these preparations with each other, with UV light or with systemic drugs often lead to improved effectiveness and tolerability when compared with the respective monotherapy. In private offices, the combination of calcipotriol with various corticosteroids is very commonly prescribed for patients with mild to moderate psoriasis. This combination can be sequentially applied twice daily or -- in a newly introduced fixed preparation -- once daily. In severe psoriasis requiring systemic treatment a concomitant effective topical treatment regimen can greatly improve the overall longtime management in affected patients.
Literatur
Braun-Falco O (1965) Zur Praxis der Psoriasis-Behandlung. Dtsch Med Wochenschr 90:1995–1998
Galewsky E (1916) Über Cignolin, ein Ersatzpräparat des Chrysarobins. Derm Wochenschr 62:113–115
Scholz A, Kadner H (1991) 75 Jahre Cignolin. Hautarzt 42:775–778
Swanbeck G, Liden S (1966) The inhibitory effect of dithranol (anthralin) on DNA synthesis. Acta Derm Venereol 46:228–230
Gerritsen MJP (1999) Dithranol. In: van de Kerkhof PCM (ed) Textbook of psoriasis. Blackwell Science Ltd., London, pp 160–178
Kemény L, Dobozy A (2001) Dithranol. In: Korting HC, Sterry W (Hrsg) Therapeutische Verfahren in der Dermatologie. Blackwell Wissenschafts-Verlag, Berlin Wien, S 209–213
Comaish S (1965) Ingram method of treating psoriasis. Arch Dermatol 92:56–58
Pion IA, Koenig KL, Lim HW (1995) Is dermatologic usage of coal tar carcinogenic? A review of the literature. Dermatol Surg 21: 227–231
Sulzberger MB, Witten VH (1952) The effect of topically applied compound F in selected dermatoses. J Invest Dermatol 19:101–102
Barnes PJ, Adcock I (1993) Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol Sci 15:138–139
Gollnick HPM, Bonnekoh B (1999) Topical and systemic retinoids. In: van de Kerkhof PCM (ed) Textbook of psoriasis. Blackwell Science Ltd., London, pp 233–256
Esgleyes-Ribot T, Chandraratna RA, Lew-Kaya DA, Sefton J, Duvic M (1994) Response of psoriasis to a new topical retinoid, AGN 190168. J Am Acad Dermatol 30:581–590
Gollnick H, Menter A (1999) Combination therapy with tazarotene plus a topical corticosteroid for the treatment of plaque psoriasis. Br J Dermatol 140 [Suppl 54]:18–23
Lowe NJ (1999) Optimizing therapy: tazarotene in combination with phototherapy. Br J Dermatol 140 [Suppl 54]:8–11
Zügel U, Steinmeyer A, Giesen C, Asadullah K (2002) A novel immunosuppressive 1α,25-dihydroxyvitamin D3 analog with reduced hypercalcemic activity. J Invest Dermatol 119:1434–1442
Rigby WF, Waugh MG (1992) Decreased accessory cell function and costimulatory activity by 1,25-dihydroxyvitamin D3-treated monocytes. Arthritis Rheum 35:110–119
Hosomi J, Hosoi J, Abe E et al. (1983) Regulation of terminal differentiation of cultured mouse epidermal cells by 1alpha,25-dihydroxyvitamin D3. Endocrinology 113:1950–1957
Binderup L, Kragballe K (1992) Origin of the use of calcipotriol in psoriasis treatment. Rev Contemporary Pharmacotherapy 23:401–409
Fogh K, Kragballe K (1999) Vitamin D3 Analogues. In: van de Kerkhof PCM (ed) Textbook of psoriasis. Blackwell Science Ltd., London, pp 121–147
Langner A, Ashton P, van de Kerkhof PCM, Verjans H (1996) A long-term multicentre assessment of the safety and tolerability of calcitriol ointment in the treatment of chronic plaque psoriasis. Br J Dermatol 135:385–389
Van de Kerkhof PCM, Berth-Jones J, Griffiths CEM et al. (2002) Long-term efficacy and safety of tacalcitol ointment in patients with chronic plaque psoriasis. Br J Dermatol 146:414–422
Kerscher M, Volkenandt M, Plewig G, Lehmann P (1993) Combination phototherapy of psoriasis with calcipotriol and narrow-band UVB. Lancet 342:923
Molin L (1999) Topical calcipotriol combined with phototherapy for psoriasis. Dermatology 198:375–381
Lehmann B, Genehr T, Knuschke P et al. (2001) UVB-induced conversion of 7-dehydrocholesterol to 1alpha,25-dihydroxyvitamin D3 in an in vitro human skin equivalent model. J Invest Dermatol 117:1179–1185
Frappaz A, Thivolet J (1993) Calcipotriol in combination with PUVA: a randomized double blind placebo study in severe psoriasis. Eur J Dermatol 3:351–354
Speight EL, Farr PM (1994) Calcipotriol improves the response of psoriasis to PUVA. Br J Dermatol 130:79–82
Ortonne JP (1994) Psoriasis: new therapeutic modality by calcipotriol and betamethason dipropionate. Nouvelle Dermatologique 13:746–751
Wozel G (1994) Effektivität der Kombinationsbehandlung mit Calcipotriol und Fluocinolonacetonid im Psoriasis Plaque-Test. Akt Dermatol 20:155–158
Lebwohl M (1997) Topical application of calcipotriene and corticosteroids: combination regimes. J Am Acad Dermatol 37:S55–58
Ruzicka T, Lorenz B (1998) Comparison of calcipotriol monotherapy and a combination of calcipotriol and betamethasone valerate after 2 weeks' treatment with calcipotriol in the topical theapy of psoriasis vulgaris: a multicentre, double-blind, randomized study. Br J Dermatol 138:254–258
Kragballe K, Barnes L, Hamberg KJ et al. (1998) Calcipotriol cream with or without concurrent topical corticosteroid in psoriasis: tolerability and efficacy. Br J Dermatol 139:649–654
Douglas WS, Poulin Y, Decroix J et al. (2002) A new calcipotriol/betamethasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris. Acta Derm Venereol 82:131–135
Kaufmann R, Bibby AJ, Bissonnette R et al. (2002) A new calcipotriol/betamethasone dipropionate formulation (Daivobet™) is an effective once-daily treatment for psoriasis vulgaris. Dermatology 205:389–393
Guenther L, Cambazard F, van de Kerkhof PCM et al. (2002) Efficacy and safety of a new combination of calcipotriol and betamethasone dipropionate (once or twice daily) compared to calcipotriol (twice daily) in the treatment of psoriasis vulgaris: a randomized, double-blind, vehicle-controlled clinical trial. Br J Dermatol 147:316–323
Katz HI (1997) Combined topical calcipotriene ointment 0,005% and various systemic therapies in the treatment of plaque-type psoriasis vulgaris: Review of the literature and results of a survey sent to 100 dermatologists. J Am Acad Dermatol 37:S62–S68
Mrowietz U, Gräber M, Bräutigam M et al. (1998) The novel ascomycin derivative SDZ ASM 981 is effictive for psoriasis when used topically under occlusion. Br J Dermatol 139:992–996
Remitz A, Reitamo S, Erkko P, Granlund H, Lauerma AI (1999) Tacrolimus ointment improves psoriasis in a microplaque assay. Br J Dermatol 141:103–107
Yamamoto T, Nishoioka K (2000) Topical tacrolimus is effective for facial lesions of psoriasis. Acta Derm Venereol 80:451
Zonneveld IM, Rubins A, Jablonska S et al. (1998) Topical tacrolimus is not effective in chronic plaque psoriasis. Arch Dermatol 134:1101–1102
Erdogan M, Wright JR, McAlister VC (2002) Liposomal tacrolimus lotion as a novel topical agent for treatment of immune-mediated skin disorders: experimental studies in a murine model. Br J Dermatol 146:964–967
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Aschoff, R., Wozel, G. & Meurer, M. Aktuelle Aspekte der topischen Psoriasisbehandlung. Hautarzt 54, 237–241 (2003). https://doi.org/10.1007/s00105-003-0498-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00105-003-0498-1